| [1] |
National Cancer Institute. Breast cancer treatment during pregnancy(PDQ®)-health professional version[EB/OL]. (2024-12-04)[2024-12-24].
URL
|
| [2] |
Loibl S, Azim HA, Bachelot T, et al. ESMO Expert Consensus Statements on the management of breast cancer during pregnancy (PrBC)[J]. Ann Oncol，2023，34(10)：849-866.
|
| [3] |
中国人体健康科技促进会生育力保护与保存专业委员会，国际妇科内分泌学会中国妇科内分泌学分会. 妊娠期乳腺癌患者生育力保护专家共识[J]. 中国临床医生杂志，2022，50(7)：772-777.
|
| [4] |
Amant F, Loibl S, Neven P, et al. Breast cancer in pregnancy[J]. Lancet，2012，379(9815)：570-579.
|
| [5] |
中国抗癌协会乳腺癌专业委员会，中华医学会肿瘤学分会乳腺肿瘤学组．中国抗癌协会乳腺癌诊治指南与规范(2024年版)[J]. 中国癌症杂志，2023，33(12)：1092-1186.
|
| [6] |
Nichols HB, de González AB, Lacey JV, et al. Declining incidence of contralateral breast cancer in the United States from 1975 to 2006[J]. J Clin Oncol，2011，29(12)：1564-1569.
|
| [7] |
Reiner AS, Sisti J, John EM, et al. Breast cancer family history and contralateral breast cancer risk in young women: an update from the women′s environmental cancer and radiation epidemiology study[J]. J Clin Oncol，2018，36(15)：1513-1520.
|
| [8] |
National Comprehensive Cancer Network.NCCN guidelines for breast cancer during pregnancy[EB/OL]. (2023-12-20)[2024-12-24].
URL
|
| [9] |
Shao C, Yu Z, Xiao J, et al. Prognosis of pregnancy-associated breast cancer: a meta-analysis[J]. BMC Cancer，2020，20(1)：746.
|
| [10] |
Margioula-Siarkou G, Margioula-Siarkou C, Petousis S, et al. Breast carcinogenesis during pregnancy: molecular mechanisms, maternal and fetal adverse outcomes[J]. Biology (Basel)，2023，12(3)：408.
|
| [11] |
Wohlfahrt J, Andersen PK, Mouridsen HT, et al. Risk of late-stage breast cancer after a childbirth[J]. Am J Epidemiol，2001，153(11)：1079-1084.
|
| [12] |
Endogenous Hormones and Breast Cancer Collaborative Group. Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies[J]. Lancet Oncol，2013，14(10)：1009-1019.
|
| [13] |
中华医学会外科学分会乳腺外科学组. 中国妊娠期与哺乳期乳腺癌临床实践指南(2022版)[J]. 中国实用外科杂志，2022，42(2)：146-150.
|
| [14] |
中华医学会外科学分会乳腺外科学组. 妊娠相关性乳腺癌临床诊治专家共识(2020版)[J]. 中华临床医师杂志(电子版)，2020，14(5)：321-325.
|
| [15] |
Loibl S, Schmidt A, Gentilini O, et al. Breast cancer diagnosed during pregnancy: adapting recent advances in breast cancer care for pregnant patients[J]. JAMA Oncol，2015，1(8)：1145-1153.
|
| [16] |
Chen Q, Qiu Y, Zhang M, et al. Clinical practice guidelines for pregnancy-associated breast cancer: Chinese society of breast surgery (CSBrS) practice guidelines 2021[J]. Chin Med J (Engl)，2021，134(20)：2395-2397.
|
| [17] |
Cordeiro CN, Gemignani ML. Breast cancer in pregnancy: avoiding fetal harm when maternal treatment is necessary[J]. Breast J，2017，23(2)：200-205.
|
| [18] |
郭惠敏，王子莲. 乳腺癌与妊娠研究进展[J].中华围产医学杂志，2013，16(11)：696-700.
|
| [19] |
Shachar SS, Gallagher K, McGuire K, et al. Multidisciplinary management of breast cancer during pregnancy[J]. Oncologist，2017，22(3)：324-334.
|
| [20] |
Alexander A, Samlowski WE, Grossman D, et al. Metastatic melanoma in pregnancy: risk of transplacental metastases in the infant[J]. J Clin Oncol，2003，21(11)：2179-2186.
|
| [21] |
Froehlich K, Stensheim H, Markert UR, et al. Breast carcinoma in pregnancy with spheroid-like placental metastases-a case report[J]. APMIS，2018，126(5)：448-452.
|
| [22] |
Froehlich K, Schmidt A, Heger JI, et al. Breast cancer, placenta and pregnancy[J]. Eur J Cancer，2019，115：68-78.
|
| [23] |
郑晓芳，魏宋荃，黄真轩，等. 妊娠合并乳腺癌的临床特点及预后分析[J/OL]. 中华产科急救电子杂志，2023，12(2)：85-92.
|
| [24] |
Mangla M, Palo S, Kumar N. Transplacental cancer transmission: a comprehensive review focusing on mechanisms, challenges, and maternal-fetal outcomes[J]. J Turk Ger Gynecol Assoc，2025，26(3)：212-229.
|